A. D'Abramo

Seroepidemiology of human bocavirus defined using recombinant virus-like particles.

J. Kahn, P. Tattersall, S. Cotmore, 2008, The Journal of infectious diseases.

Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene

M. Agbandje-McKenna, P. Tattersall, S. Cotmore, 2018, Viruses.

Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction

T. Baker, R. McKenna, M. Agbandje-McKenna, 2017, Viruses.

Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly.

P. Tattersall, S. Cotmore, A. D'abramo, 1999, Virology.

cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses.

J. Van Damme, P. Tattersall, S. Cotmore, 1999, Human gene therapy.

Host range mutants of Minute Virus of Mice with a single VP2 amino acid change require additional silent mutations that regulate NS2 accumulation.

P. Tattersall, S. Cotmore, A. D'abramo, 2005, Virology.

Cryo-EM maps reveal five-fold channel structures and their modification by gatekeeper mutations in the parvovirus minute virus of mice (MVM) capsid.

A. Makhov, J. Conway, S. Hafenstein, 2017, Virology.

Differential roles for the C-terminal hexapeptide domains of NS2 splice variants during MVM infection of murine cells.

P. Tattersall, A. D'abramo, Z. Ruiz, 2006, Virology.